Merdury Biopharmaceutical Corporation (TPEX:6932)

Market Cap	3.04B -44.5%
Revenue (ttm)	n/a
Net Income	-67.23M
EPS	-0.16
Shares Out	422.03M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	449,249
Open	6.89
Previous Close	6.89
Day's Range	6.61 - 7.21
52-Week Range	4.95 - 12.80
Beta	-1.25
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 10, 2026

About Merdury Biopharmaceutical

Merdury Biopharmaceutical Corporation engages in the development of drugs for unmet needs in Taiwan. The company develops StackDose platform, a drug development technology platform that integrates drug formulation, 3D powder printing, and hardware and software technologies to create drug-specific 3D printing production equipment, which can be used as a foundation for pharmaceutical companies to provide hosted services and in-house product development. Merdury Biopharmaceutical Corporation was founded in 2019 and is headquartered in New Taipei C...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2019
• Employees: 16
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6932